Tumorigenesis from non-alcoholic steatohepatitis to hepatocellular carcinomaJunjie Yu, Utpal B.Pajvani544-546
Immunotherapy prototype Mark 3.0 model in primary liver cancer:adding locoregional stereotactic therapy and prognostic factors classification managementXu Yang, Nan Zhang, Yang Song, Xiaobo Yang, Xinting Sang, Haitao Zhao547-552
Precision intervention of cell type-specific targeting is required for future cancer immunotherapyYitong Cai, Anli Zhang, Changzheng Lu553-554
Therapeutic antibodies for precise cancer immunotherapy:current and future perspectivesLongchao Liu, Jiahui Chen555-569
Understanding recurrent pregnancy loss:recent advances on its etiology,clinical diagnosis,and managementChunwei Cao, Shiyu Bai, Jing Zhang, Xiaoyue Sun, Anming Meng, Hui Chen570-589
Atypical functions of xenobiotic receptors in lipid and glucose metabolismJingyuan Wang, Peipei Lu, Wen Xie611-624
